Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

KITTEE TRC20 Token Ad

TOMDF Quote Trading Chart Todos Medical Ltd


home / stock / tomdf / tomdf quote

$0.0315 Last:

173.91% Change Percent:

$0.034 Open:

$0.0115 Previous Close:

$0.0348 High:

$0.0271 Low:

16,742,370 Volume:

12/31/1969 07:00:00 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

TOMDF Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2022-08-120.0340.01150.03480.027116,742,370
2022-08-110.0350.01150.0350.029912,337,931
2022-08-100.03590.01150.04160.028530,195,668
2022-08-090.03560.01150.04190.030164,351,532
2022-08-080.0270.01150.03450.02458,961,582
2022-08-050.02450.01150.02640.020125,911,523
2022-08-040.02010.01150.02470.019165,104,372
2022-08-030.01350.01150.01990.012372,600,346
2022-08-020.0120.01150.0120.0112581,691
2022-08-010.0120.01150.0120.01032,681,653
2022-07-290.0120.01150.01210.01122,585,346
2022-07-280.01150.01150.0120.01151,887,753
2022-07-260.01150.01150.01190.0112720,199
2022-07-190.01230.01180.01230.01162,359,679
2022-07-180.01220.01220.01230.01151,176,826
2022-07-150.01190.01220.01230.0118608,946
2022-07-140.0120.01190.0120.01171,009,830
2022-07-130.01240.0120.01240.01151,710,262
2022-07-120.01180.0120.01240.01151,372,598
2022-07-110.01240.0120.01250.01181,289,365
Stock Information

Todos Medical Ltd Company Name:

TOMDF Stock Symbol:

OTC Market:

MENU
TOMDF TOMDF Quote TOMDF Short TOMDF News TOMDF Articles TOMDF Message Board
Get TOMDF Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

KITTEE TRC20 Token Ad
RECENT TOMDF NEWS
  • TOMDF - Todos Medical Completes Trial Design for Tollovid Long COVID Clinical Study in Adults

    §    3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens §    Finalizing contracts with two Long COVID clinics to recruit patients §    Institutional Review Board (IRB) protocol submission imminent ...

  • TOMDF - Todos Medical Completes Trial Design for Tollovid(TM) Long COVID Clinical Study in Adults

    § 3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens § Finalizing contracts with two Long COVID clinics to recruit patients § Institutional Review Board (IRB) protocol submission imminent New York, NY, and Tel Aviv, I...

  • TOMDF - Todos Medical Announces PCR Validation of Wound and Respiratory Pathogen Panels at CLIA/CAP Lab Provista Diagnostics

    New York, NY, and Tel Aviv, ISRAEL , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Provista Diagnostics has ...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Join us on Discord

Join us on Discord

Follow us on discord to get immediate notifications!

Check out the New Market Wire News Discord Bot

Discord


Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2022 Market Wire News